Storia in 2 fonti

Rush for GLP-1 weight-loss and diabetes drugs plateaus, says industry tracker

The GLP-1 weight-loss and diabetes drug market stabilizes as generics gain traction, with innovators maintaining steady sales, reports Pharmatrack.

Raccontata da

thehindubusinessline.com

economictimes.indiatimes.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo1 g fa

Rush for GLP-1 weight-loss and diabetes drugs plateaus, says industry tracker

The GLP-1 weight-loss and diabetes drug market stabilizes as generics gain traction, with innovators maintaining steady sales, reports Pharmatrack.

originale

economictimes.indiatimes.com1 g fa

Wegovy, Ozempic regain weight as Indian generics fall behind

Novo Nordisk's weight-loss drugs are regaining market share from Indian generics. Innovator brands show steady month-on-month sales growth, unlike generics. Eli Lilly's tirzepatide brands also experienced sales growth…

Leggi questa versione →

Timeline cronologica

mercoledì 8 luglio 2026·thehindubusinessline.com
Rush for GLP-1 weight-loss and diabetes drugs plateaus, says industry tracker
The GLP-1 weight-loss and diabetes drug market stabilizes as generics gain traction, with innovators maintaining steady sales, reports Pharmatrack.
mercoledì 8 luglio 2026·economictimes.indiatimes.com
Wegovy, Ozempic regain weight as Indian generics fall behind
Novo Nordisk's weight-loss drugs are regaining market share from Indian generics. Innovator brands show steady month-on-month sales growth, unlike generics. Eli Lilly's…